Wellington Management Group’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.7M | Sell |
1,465,053
-1,723,689
| -54% | -$19.6M | ﹤0.01% | 1032 |
|
|
2025
Q1 | $37.9M | Sell |
3,188,742
-397,863
| -11% | -$4.73M | 0.01% | 770 |
|
|
2024
Q4 | $67.6M | Buy |
3,586,605
+104,500
| +3% | +$1.97M | 0.01% | 635 |
|
|
2024
Q3 | $78.2M | Buy |
3,482,105
+280,240
| +9% | +$6.3M | 0.01% | 593 |
|
|
2024
Q2 | $66.8M | Buy |
3,201,865
+2,968,729
| +1,273% | +$62M | 0.01% | 635 |
|
|
2024
Q1 | $3.43M | Buy |
233,136
+27,812
| +14% | +$409K | ﹤0.01% | 1419 |
|
|
2023
Q4 | $2.12M | Buy |
205,324
+60,271
| +42% | +$622K | ﹤0.01% | 1483 |
|
|
2023
Q3 | $1.14M | Buy |
145,053
+4,163
| +3% | +$32.7K | ﹤0.01% | 1586 |
|
|
2023
Q2 | $1.41M | Buy |
140,890
+70,361
| +100% | +$703K | ﹤0.01% | 1548 |
|
|
2023
Q1 | $626K | Sell |
70,529
-2,475
| -3% | -$22K | ﹤0.01% | 1792 |
|
|
2022
Q4 | $802K | Sell |
73,004
-1,525
| -2% | -$16.7K | ﹤0.01% | 1688 |
|
|
2022
Q3 | $971K | Buy |
74,529
+21,425
| +40% | +$279K | ﹤0.01% | 1661 |
|
|
2022
Q2 | $673K | Sell |
53,104
-789,269
| -94% | -$10M | ﹤0.01% | 1750 |
|
|
2022
Q1 | $11.8M | Sell |
842,373
-319,943
| -28% | -$4.48M | ﹤0.01% | 1161 |
|
|
2021
Q4 | $33.6M | Sell |
1,162,316
-63,742
| -5% | -$1.85M | 0.01% | 955 |
|
|
2021
Q3 | $36.7M | Sell |
1,226,058
-168,833
| -12% | -$5.06M | 0.01% | 914 |
|
|
2021
Q2 | $37M | Buy |
1,394,891
+34,465
| +3% | +$914K | 0.01% | 925 |
|
|
2021
Q1 | $42.3M | Sell |
1,360,426
-1,087,158
| -44% | -$33.8M | 0.01% | 848 |
|
|
2020
Q4 | $80.3M | Sell |
2,447,584
-920,938
| -27% | -$30.2M | 0.01% | 647 |
|
|
2020
Q3 | $117M | Buy |
+3,368,522
| New | +$117M | 0.02% | 489 |
|